|
Market Closed -
Other stock markets
|
5-day change | 1st Jan Change | ||
| 133.60 INR | +2.02% |
|
+2.57% | +62.43% |
| 05-22 | IOL Chemicals and Pharmaceuticals Limited, Q4 2026 Earnings Call, May 22, 2026 | |
| 05-20 | IOL Chemicals and Pharmaceuticals March-quarter consol profit 531.6 million rupees | RE |
| Market Cap | 39.22B 416M 364M 336M 315M 590M 602M 4.04B 1.56B 19.38B 1.56B 1.53B 67.21B | P/E 2026 |
15.5x | P/E 2027 * | - |
|---|---|---|---|---|---|
| Enterprise Value | 39.22B 416M 364M 336M 315M 590M 602M 4.04B 1.56B 19.38B 1.56B 1.53B 67.21B | EV / Sales 2026 |
0.92x | EV / Sales 2027 * | 1.53x |
| Free-Float |
33.03% | Yield 2026 * |
-
| Yield 2027 * | - |
Last Transcript: IOL Chemicals and Pharmaceuticals Limited
| 1 day | +2.02% | ||
| 1 week | +2.57% | ||
| Current month | +3.82% | ||
| 1 month | +1.72% | ||
| 3 months | +71.44% | ||
| 6 months | +63.93% | ||
| Current year | +62.43% |
| 1 week | 129.7 | 139 | |
| 1 month | 121.3 | 139.85 | |
| Current year | 67.14 | 139.85 | |
| 1 year | 67.14 | 139.85 | |
| 3 years | 57.51 | 139.85 | |
| 5 years | 54.44 | 143.06 | |
| 10 years | 8.4 | 179.68 |
| Manager | Title | Age | Since |
|---|---|---|---|
Vikas Gupta
CEO | Chief Executive Officer | 34 | - |
Pardeep Khanna
DFI | Director of Finance/CFO | - | - |
Abhay Raj Singh
CMP | Compliance Officer | - | 2019-11-13 |
| Director | Title | Age | Since |
|---|---|---|---|
| Chairman | 73 | - | |
Varinder Gupta
CHM | Chairman | 63 | 2007-08-31 |
Vikas Gupta
BRD | Director/Board Member | 34 | 2015-05-28 |
| Change | 5-day change | 1-year change | 3-year change | Capi.($) | ||
|---|---|---|---|---|---|---|
| +2.02% | +2.57% | +37.08% | +55.33% | 416M | ||
| +7.13% | +9.97% | +55.80% | +160.09% | 1,077B | ||
| +3.99% | +11.50% | +67.09% | +55.96% | 613B | ||
| +4.20% | +17.03% | +38.97% | +91.06% | 448B | ||
| +0.99% | +4.85% | +28.17% | +23.89% | 332B | ||
| +1.82% | +8.19% | +40.04% | +27.95% | 293B | ||
| +0.22% | +6.75% | +31.30% | +42.34% | 286B | ||
| +0.73% | +8.53% | -27.33% | -39.55% | 215B | ||
| +1.56% | +6.14% | +29.30% | +60.97% | 193B | ||
| +3.26% | +3.33% | +15.55% | +68.24% | 159B | ||
| Average | +2.59% | +7.62% | +31.60% | +54.63% | 361.65B | |
| Weighted average by Cap. | +3.85% | +8.93% | +41.75% | +80.17% |
| 2026 | 2027 * | |
|---|---|---|
| Net sales | 23.04B 244M 214M 197M 185M 346M 354M 2.37B 918M 11.38B 917M 897M 39.48B | 25.66B 272M 239M 220M 206M 386M 394M 2.64B 1.02B 12.68B 1.02B 999M 43.98B |
| Net income | 1.3B 13.74M 12.05M 11.1M 10.4M 19.49M 19.9M 133M 51.64M 641M 51.59M 50.46M 2.22B | - |
| Net Debt | - | - |
Employees
2,891
Sector
Pharmaceuticals
| Date | Price | Change | Volume |
|---|---|---|---|
| 26-06-25 | ₹133.60 | +2.02% | 258,167 |
| 26-06-24 | ₹130.95 | -1.43% | 175,038 |
| 26-06-23 | ₹132.85 | +1.68% | 178,301 |
| 26-06-22 | ₹130.65 | +0.31% | 155,846 |
| 26-06-19 | ₹130.25 | +1.60% | 59,655 |
Sell
Buy

Mean consensus
BUY
Number of Analysts
1
Last Close Price
133.60INR
Average target price
150.00INR
Spread / Average Target
+12.28%
Quarterly revenue - Rate of surprise
- Stock Market
- Stocks
- IOLCP Stock
Select your edition
All financial news and data tailored to specific country editions

















